You are here

patents

Merck takes Keytruda patent dispute with Johns Hopkins University from the court to the patent office

Fierce Pharma

Thu, 03/14/24 - 11:29 am

Former U.S. patent head on why federal march-in rights for drugs would be a ‘devastating’ mistake

Pharma Voice

Thu, 03/14/24 - 11:13 am

march-in rights

Merck’s Bridion Could Face Generic Pressure from Hikma Ahead of Patent Expiry Date

BioSpace

Tue, 02/27/24 - 10:18 am

muscle relaxants

FTC calls for 'expansive and flexible' use of march-in rights to rein in

Fierce Pharma

Tue, 02/6/24 - 11:35 pm

march-in rights

The FTC is attacking drugmakers’ ‘patent thickets’

Medical Marketing and Media

Wed, 01/31/24 - 10:24 pm

patent thickets

J&J focuses on newer meds to offset Stelara patent cliff

BioPharma Dive

Wed, 01/24/24 - 10:52 am

Seagen patent in Daiichi Sankyo ADC dispute nixed by USPTO News

Pharmaphorum

Wed, 01/17/24 - 09:38 am

Apple to Remove Blood-Oxygen Tool to Circumvent US Watch Ban, US Customs Decides

Medical Devices and Diagnostics Industry

Wed, 01/17/24 - 09:22 am

Regeneron Gains After Eye-Drug Patent Victory Over Viatris

Yahoo/Bloomberg

Sun, 12/31/23 - 11:46 am

Apple Watch Ban Temporarily Halted

Medical Devices and Diagnostics Industry

Wed, 12/27/23 - 11:04 pm

Apple to halt Apple Watch Series 9 and Apple Watch Ultra 2 sales in the US this week due to Masimo dispute

9to5Mac

Tue, 12/19/23 - 10:15 am

FTC warns pharma companies on excessive drug patenting

Medical Marketing and Media

Fri, 12/8/23 - 10:05 am

Teva Pharmaceutical

US sets policy to seize government-funded drug patents if price deemed too high

Reuters

Thu, 12/7/23 - 11:57 am

government-funded patents

Daiichi Sankyo unit claims $182m in Novartis patent dispute

Pharmaphorum

Wed, 12/6/23 - 10:31 am

Samsung Bioepis, J&J Ink Settlement and License Deal for Stelara Biosimilar

BioSpace

Thu, 11/30/23 - 11:20 pm

Samsung Bioepsis

Teva drops patent case against Lilly after two Ajovy patents deemed invalid

Fierce Pharma

Tue, 11/28/23 - 11:40 pm

Teva Pharmaceutical

AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz, other generic players

Fierce Pharma

Wed, 11/22/23 - 11:39 am

Intas Pharmaceuticals

European Patent Office declares Moderna mRNA patent invalid

Reuters

Tue, 11/21/23 - 11:39 am

Moderna Therapeutics

AbbVie, AstraZeneca, Boehringer and more face FTC's ire for 'improper' patent listings

Fierce Pharma

Tue, 11/7/23 - 11:08 pm

Boehringer Ingelheim

There's a Silver Lining in Pfizer's Dark Cloud

Motley Fool

Fri, 11/3/23 - 10:56 am

Pages